MUC3A通过MAPK/ERK途径促进胆管癌的进展
Baijie Feng1, Wei Su2, Lina Hu1
1Fudan University Clinical Research Center for Cell-Based Immunotherapy & Department of Oncology, Fudan University Pudong Medical Center, 2800 Gongwei Road, Shanghai, 201399, People's Republic of China.
素3A (MUC3A) 促进胆管癌 (CCA) 细胞的增殖和转移. 这项研究表明,MUC3A通过ERK信号通路调节CCA进展,提供潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 胆管癌 (CCA) 是一种流行的胆管癌,具有诊断挑战.
- 对CCA的早期标志物和治疗目标对于改善患者的治疗结果至关重要.
研究的目的:
- 研究素3A (MUC3A) 在胆管癌 (CCA) 细胞发生和发育中的作用.
- 阐明MUC3A影响CCA进展的潜在分子机制.
主要方法:
- 在正常胆道细胞与CCA细胞中比较MUC3A表达.
- 在CCA细胞系中利用了lentivirus介导的MUC3A淘汰.
- 通过CCK-8,殖民地形成,流细胞计,,和Transwell测定来评估增殖,细胞循环,入侵和迁移.
- 通过Western blot分析探索了该机制,专注于ERK信号通路.
主要成果:
- 素3A (MUC3A) 在胆管癌 (CCA) 中显著上调.
- 通过调节细胞循环,MUC3A增强了CCA细胞的增殖.
- MUC3A通过表皮-介质细胞过渡促进了CCA细胞的入侵和迁移.
- 通过ERK信号通路,MUC3A调节了CCA的扩散和转移.
结论:
- 素3A (MUC3A) 在胆管癌 (CCA) 进展中起着重要作用.
- 通过激活ERK信号通路,MUC3A促进了CCA细胞的增殖和转移.
- 准MUC3A或ERK通路可能为CCA提供新的治疗策略.
更多相关视频
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
07:59Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
相关概念视频
MAPK Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
